Authors: Pan, LC Carpino, PA Lefker, BA Ragan, JA Toler, SM Pettersen, JC Nettleton, DO Ng, O Pirie, CM Chidsey-Frink, K Lu, BH Nickerson, DF Tess, DA Mullins, MA MacLean, DB DaSilva-Jardine, PA Thompson, DD

Citation: Lc. Pan et al., Preclinical pharmacology of CP-424,391, an orally active pyrazolidinone-piperidine growth hormone secretagogue (vol 14, pg 121, 2001), ENDOCRINE, 14(3), 2001, pp. 437-437

Authors: Ke, HZ Crawford, DT Qi, H Pirie, CM Simmons, HA Chidsey-Frink, KL Chen, HK Jee, WSS Thompson, DD

Citation: Hz. Ke et al., Droloxifene does not blunt bone anabolic effects of prostaglandin E-2, butmaintains prostaglandin E-2-restored bone in aged, ovariectomized rats, BONE, 24(1), 1999, pp. 41-47